IP Library Granted Patent US 8,460,906
Granted Patent B2
US 8,460,906 · App. 12/936,611 · Granted Jun 11, 2013

Immobilized product tolerant microorganisms

Inventors: Pamela Reilly Contag (San Jose, CA); Stacy M. Burns-Guydish (Campbell, CA); Hendrikus J. Meerman (Scotts Valley, CA); David C. Walther (Oakland, CA); John C. Chen (Bethlehem, PA); Alvin W. Nienow (Edgbaston, GB); Ian Maddox (Eden Terrace, NZ)
Assignee: Cobalt Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,460,906
App. No.
12/936,611
Granted
Jun 11, 2013
Kind
B2
Abstract

Methods for mutagenizing and selecting microorganisms with increased product tolerance are provided. Additionally, methods and systems are disclosed for culturing the microorganisms to produce products.

Claims (48)

1. A system for making a solvent or organic acid, comprising a bioreactor that comprises:

a) growth medium in contact with a solid or semi-solid support; and

b) product tolerant microorganisms of the Clostridium genus on the solid or semi-solid support, wherein said microorganisms produce the solvent or organic acid and have previously been mutagenized and selected for tolerance to the solvent or organic acid on a solid or semi-solid support in the presence of the solvent or organic acid, wherein the tolerance of the selected microorganisms to the solvent or organic acid is greater on a solid or semi-solid support than the tolerance to the solvent or organic acid exhibited when the selected microorganisms are cultured in a liquid media, and wherein the microorganisms have been selected to exhibit at least 125% tolerance to the solvent or organic acid in comparison to the tolerance of corresponding non-mutagenized microorganisms.

2. The system of claim 1 , wherein the microorganisms are cultured in a continuous culture.

3. The system of claim 2 , further comprising the recycle and reutilization of fermentation broth nutrients and minerals recovered during product purification.

4. A system according to claim 1 , wherein the bioreactor is a packed bed or fluidized bed bioreactor.

5. A system according to claim 1 , wherein the bioreactor comprises:

a) a packed bed zone, said packed bed zone adapted to hold a solid support;

b) a bed expansion zone coupled to said packed bed zone, said bed expansion zone adapted to hold said solid support when said bioreactor is operated in an expanded bed mode; and

c) a particle disengagement zone coupled to said bed expansion zone, said particle disengagement zone adapted to prevent egress of said solid support from said bioreactor.

6. A system according to claim 5 , wherein the bioreactor further comprises an inlet distribution zone coupled to the packed bed zone.

7. A system according to claim 6 , wherein the bioreactor has a pressure drop in the inlet distribution zone that is no more than 30% of the total pressure drop across the length of the bioreactor.

8. A system according to claim 5 , wherein the diameter of the particle disengagement zone is larger than the diameter of the packed bed zone or the expanded bed zone.

9. A system according to claim 1 , comprising at least two bioreactors arranged in series or parallel.

10. A system according to claim 9 , wherein the solid or semi-solid support is within at least one of the at least two of the bioreactors.

11. A system according to claim 9 , wherein at least one of the at least two bioreactors comprises a continuous culture.

12. A system according to claim 1 , wherein the solvent or organic acid is butanol.

13. A system according to claim 1 , wherein the microorganisms on the solid or semi-solid support comprise a biofilm.

14. A system according to claim 1 , wherein the microorganisms of the Clostridium genus comprise Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium puniceum, Clostridium saccharobutylicum, Clostridium aurantibutyricum, Clostridium tetanomorphum, Clostridium thermosaccharolyticum, Clostridium butyricum, Clostridium cellulolyticum, Clostridium phytofermentans, Clostridium saccharoperbutylacetonicum, Clostridium thermomorphum, Clostridium thermobutyricum, Clostridium thermocellum , or Clostridium pasteurianum.

15. A system according to claim 1 , wherein the solid or semi-solid support in the bioreactor comprises a porous material.

16. A system according to claim 1 , wherein the solid or semi-solid support in the bioreactor comprises a material selected from bone char, synthetic polymers, natural polymers, inorganic materials, or organic materials.

17. A system according to claim 14 , wherein the microorganisms of the Clostridium genus comprise Clostridium acetobutylicum, Clostridium saccharobutylicum , or Clostridium beijerinckii.

18. A system according to claim 1 , wherein the bioreactor comprises a packed bed zone, said packed bed zone adapted to hold a solid support, wherein the bioreactor further comprises an inlet distribution zone coupled to the packed bed zone and wherein the bioreactor has a pressure drop in the inlet distribution zone that is no more than 30% of the total pressure drop across the length of the bioreactor.

19. A method for making a solvent or organic acid in a system according to claim 1 , comprising:

culturing the product tolerant microorganisms of the Clostridium genus on the solid or semi-solid support under product producing conditions in the bioreactor.

20. The method of claim 19 wherein the Clostridium species is Clostridium acetobutylicum, Clostridium saccharobutylicum or Clostridium beijerinckii.

21. The method of claim 19 , wherein the solvent or organic acid is butanol.

22. The method of claim 21 , wherein the microorganisms exhibit tolerance to at least 2% butanol.

23. The method of claim 19 , wherein the microorganisms are immobilized on the solid or semi-solid support.

24. The method of claim 23 , wherein immobilizing the mutagenized and selected microorganisms on the solid or semi-solid support comprises circulating fermentation media containing the mutagenized and selected cells through the bioreactor.

25. The method of claim 23 wherein the solid or semi-solid support in the bioreactor comprises a porous material.

26. The method of claim 23 wherein the solid or semi-solid support in the bioreactor comprises a material selected from bone char, synthetic polymers, natural polymers, inorganic materials, or organic materials.

27. The method of claim 19 wherein the microorganisms are cultured in batch, fed-batch, or continuous culture.

28. The method of claim 19 , wherein the solvent or organic acid is butanol and the Clostridium microorganisms are cultured under conditions that provide for a butanol productivity of at least 6 g/L/hr.

29. The method of claim 19 , wherein the microorganisms comprise a heterologous gene.

30. The method of claim 29 , wherein the heterologous gene encodes an enzyme in a product biosynthetic pathway.

31. The method of claim 30 , wherein the enzyme is selected from phosphotransacetylase, acetate kinase, NAD-dependent beta-hydroxybutyryl-CoA dehydrogenase, butyryl-CoA dehydrogenase, 3-hydroxybutyryl-COA dehydratase, acetyl-CoA acetyltransferase, butyrate kinase, phosphate butyryltransferase, NADH-dependent butanol dehydrogenase B, NADH-dependent butanol dehydrogenase A, aldehyde-alcohol dehydrogenase, acetyl coenzyme A acetyltransferase, aldehyde dehydrogenase, butyrate-acetoacetate COA- transferase subunit A, butyrate-acetoacetate COA-transferase subunit B, and acetoacetate decarboxylase.

32. A method of making a solvent or organic acid according to claim 19 ,

wherein the bioreactor comprises:

a) a packed bed zone, comprising solid support therein, said solid support comprising said product tolerant microorganisms;

b) a bed expansion zone coupled to said packed bed zone adapted for containing said solid support when said bioreactor is operated in an expanded bed mode; and

c) a particle disengagement zone coupled to said bed expansion zone, said particle disengagement zone adapted to prevent egress of said solid support from said bioreactor.

33. A method according to claim 23 , wherein the microorganisms form a biofilm on the solid or semi-solid support.

34. A method according to claim 19 , further comprising harvesting the solvent or organic acid.

35. A method according to claim 19 , wherein the bioreactor comprises a packed bed zone, said packed bed zone adapted to hold a solid support, wherein the bioreactor further comprises an inlet distribution zone coupled to the packed bed zone and wherein the bioreactor has a pressure drop in the inlet distribution zone that is no more than 30% of the total pressure drop across the length of the bioreactor.

36. A method according to claim 19 , wherein the microorganisms of the Clostridium genus comprise Clostridium acetobutylicum, Clostridium beijerinckii, Clostridium puniceum, Clostridium saccharobutylicum, Clostridium aurantibutyricum, Clostridium tetanomorphum, Clostridium thermosaccharolyticum, Clostridium butyricum, Clostridium cellulolyticum, Clostridium phytofermentans, Clostridium saccharoperbutylacetonicum, Clostridium thermomorphum, Clostridium thermobutyricum, Clostridium thermocellum , or Clostridium pasteurianum.

37. The method of claim 36 , wherein harvesting of the product comprises continuously extracting the product from the culture.

38. The method of claim 36 , wherein harvesting of the product is performed with the use of a stripping gas, solvent, absorbent material, pervaporation membrane, or distillation.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2015
From: THE WHITTEMORE COLLECTION, LTD; PINNACLE VENTURES EQUITY FUND I, L.P.; PINNACLE VENTURES EQUITY FUND I AFFILIATES, L.P.; PINNACLE VENTURES EQUITY FUND I-O, L.P.; PINNACLE VENTURES II-A, L.P.; PINNACLE VENTURES II-B, L.P.; PINNACLE VENTURES II-C, L.P.; PINNACLE VENTURES II-R, L.P.; MALAYSIAN LIFE SCIENCES CAPITAL FUND, LTD; VANTAGEPOINT VENTURE PARTNERS 2006 (Q), L.P.; VANTAGEPOINT CLEANTECH PARTNERS, L.P.; LSP BIOVENTURES C.V.; @VENTURES V, LLC; HARRIS & HARRIS GROUP, INC.
To: COBALT TECHNOLOGIES, INC.
Reel/Frame 036872/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2015
From: COBALT (ASSIGNMENT FOR THE BENEFIT OF CREDITORS) LLC
To: TALFRYN SA
Reel/Frame 036804/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2015
From: COBALT TECHNOLOGIES, INC.
To: COBALT (ASSIGNMENT FOR THE BENEFIT OF CREDITORS), LLC
Reel/Frame 036250/0743 →
SECURITY AGREEMENT Recorded May 31, 2012
From: COBALT TECHNOLOGIES, INC.
To: THE WHITTEMORE COLLECTION, LTD.; PINNACLE VENTURES EQUITY FUND I, L.P.; PINNACLE VENTURES EQUITY FUND I AFFILIATES, L.P.; PINNACLE VENTURES EQUITY FUND I-O, L.P.; PINNACLE VENTURES II-A, L.P.; PINNACLE VENTURES II-B, L.P.; PINNACLE VENTURES II-C, L.P.; PINNACLE VENTURES II-R, L.P.; LSP BIOVENTURES C.V.; @VENTURES V, LLC; VANTAGEPOINT VENTURE PARTNERS 2006 (Q), L.P.; VANTAGEPOINT CLEANTECH PARTNERS, L.P.; HARRIS & HARRIS GROUP, INC.; MALAYSIAN LIFE SCIENCES CAPITAL FUND, LTD
Reel/Frame 028307/0364 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2010
From: CONTAG, PAMELA REILLY; BURNS-GUYDISH, STACY M.; MEERMAN, HENDRIKUS J.; WALTHER, DAVID C.; CHEN, JOHN C.; NIENOW, ALVIN W.; MADDOX, IAN
To: COBALT TECHNOLOGIES, INC.
Reel/Frame 025560/0850 →
Continuity (2)
Provisional Application 61043710 · Apr 9, 2008
Related Publication 20110129887A1 · Jun 2, 2011